AVE 25.0% 0.3¢ avecho biotechnology limited

positive results from phase 1b study, page-29

  1. 671 Posts.
    Nice to see POH pulling out of the doldrums...Lets hope they finish and commercialise this one...rofl
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.